Bettany (300957): Weak performance in '23, marginal improvement in Q1 in '24
Bettany (300957): Performance is under pressure, main brand moves towards 2.0 era & organizational optimization drives management improvement
Bethany (300957): Main brand growth is gradually stabilizing, and this year is expected to consolidate the quality of operations
Bettany (300957): 2024Q1 net profit YOY +11.7%, positive performance for 24 years
Bettany (300957) 2023 Report and 2024 Quarterly Report Review: Steady Revenue Restoration, Brand Matrix, Channel Enrichment, and Organizational Structure Adjustment Results
Bethany (300957): Short-term pressure on 2023 results, long-term multi-brand matrices drive growth
Bettany (300957): Profitability in 2023 is under pressure, 24Q1 performance rebounded steadily
Bettany (300957): The trough may be over, but it will still take time for profit margins to return
Jefferies Adjusts Yunnan Botanee Bio-Technology's Price Target to 62 Yuan From 87 Yuan, Keeps at Hold
Bettany (300957): Strategy Upgrading/Organizational Optimization Expecting Continued Positive Changes in 24Q1
Bettany (300957): Q1 growth picked up significantly month-on-month, pay attention to changes in inflection points on the business data side
Bettany (300957) 2023 Annual Report and 2024 Quarterly Report Review: 24Q1 Revenue and Profit Achieved Double Digit Growth and Expecting Continued Improvement in Business
Minsheng Securities released a research report on April 28 stating that it gave Bethany (300957.SZ) a recommended rating. The main reasons for the rating include: 1) 2023 revenue +10.14% year-on-year, and revenue growth from offline channels is steady; 2)
Bettany (300957): 24Q1 performance improved month-on-month to accelerate multi-brand multi-channel construction
Bethany (300957): Deepening the brand moat and actively exploring new growth spaces
Bettany (300957): Failure to reach the goal of Double Eleven in '23 puts pressure on performance and looks forward to the effects of organizational structure & brand strategy adjustments in '24
Bettany (300957): Revenue growth in 23 years, performance under pressure for 24 years, looking forward to an improvement in business quality
Dongwu Securities released a research report on April 26 stating that it gave Bethany (300957.SZ) a purchase rating. The main reasons for the rating include: 1) the performance was pressured by 23 years, and growth resumed in 24Q1; 2) Winona's head effect
Bettany (300957): Product Focus+Organizational Adjustments Waiting for Multiple Brands to Work
Bettany (300957): Q1 Business Recovery Employee Stock Ownership Plan Helps Sensitive Skin Leaders Develop Over the Long Term
No Data